2015
DOI: 10.1111/pin.12343
|View full text |Cite
|
Sign up to set email alerts
|

Clinical implication of human leukocyte antigen (HLA)‐F expression in breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
28
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(30 citation statements)
references
References 25 publications
(58 reference statements)
2
28
0
Order By: Relevance
“…It is possible that changes in classical HLA-class II molecules and non-classical HLA-class I molecules, which we observed in childhood obesity with and without insulin resistance, can contribute to these numerous intrinsic mechanisms of glucose and lipid metabolism dysregulation as well as cellular growth, because HLA-DR receptor and non-classical HLA-class I molecules play an important role in the regulation of both immune response and proliferative processes and participate in endoplasmic reticulum stress, an important factor of insulin resistance and obesity (Schaiff et al 1992;Minchenko et al 2005;Yuzefovych et al 2013;Han and Kaufman 2014;Lee and Ozcan 2014;Carosella et al 2015;Walentowicz-Sadlecka et al 2018;Yang et al 2018). Furthermore, there is data that both HLA-DR receptor and non-classical HLA-class I molecules play an important role in tumorigenesis (Kochan et al 2013;Morandi et al 2013;Leite et al 2014;Zeestraten et al 2014;Harada et al 2015;Ishigami et al 2015;Brown et al 2016;Martinez-Canales et al 2017;Winkler et al 2017;Walentowicz-Sadlecka et al 2018;Wu et al 2018). It is interesting to note that the absent in melanoma 2 (AIM2), which is a member of the IFN-inducible nuclear proteins, associated with both infection defense and tumor pathology, mediates induction of several interferon-stimulated genes, including genes encoding the major histocompatibility complex class II antigens HLA-DRA and HLA-DRB in cancer cells (Kochan et al 2013).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is possible that changes in classical HLA-class II molecules and non-classical HLA-class I molecules, which we observed in childhood obesity with and without insulin resistance, can contribute to these numerous intrinsic mechanisms of glucose and lipid metabolism dysregulation as well as cellular growth, because HLA-DR receptor and non-classical HLA-class I molecules play an important role in the regulation of both immune response and proliferative processes and participate in endoplasmic reticulum stress, an important factor of insulin resistance and obesity (Schaiff et al 1992;Minchenko et al 2005;Yuzefovych et al 2013;Han and Kaufman 2014;Lee and Ozcan 2014;Carosella et al 2015;Walentowicz-Sadlecka et al 2018;Yang et al 2018). Furthermore, there is data that both HLA-DR receptor and non-classical HLA-class I molecules play an important role in tumorigenesis (Kochan et al 2013;Morandi et al 2013;Leite et al 2014;Zeestraten et al 2014;Harada et al 2015;Ishigami et al 2015;Brown et al 2016;Martinez-Canales et al 2017;Winkler et al 2017;Walentowicz-Sadlecka et al 2018;Wu et al 2018). It is interesting to note that the absent in melanoma 2 (AIM2), which is a member of the IFN-inducible nuclear proteins, associated with both infection defense and tumor pathology, mediates induction of several interferon-stimulated genes, including genes encoding the major histocompatibility complex class II antigens HLA-DRA and HLA-DRB in cancer cells (Kochan et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, expression of HLA-F is correlated with tumor cell invasion and metastasis (Xu et al 2013;Ishigami et al 2015). HLA-F expression was found to be enhanced in gastric adenocarcinoma, breast cancer, esophageal squamous cell carcinoma, hepatocellular carcinoma, and neuroblastoma (Zhang et al 2013;Morandi et al 2013;Harada et al 2015;Martinez-Canales et al 2017;Wu et al 2018).…”
mentioning
confidence: 98%
“…Yet in NSCLC, positive HLA-F expression is not associated with disease progression and differentiation status of the tumor [149]. The occurrence of HLA-F in breast cancer correlates with the size of tumor, but there is no evidence for nodal involvement [152].…”
Section: Hla-f In Tumorsmentioning
confidence: 98%
“…Until now, HLA-F has been detected immunohistochemically in various cancers, i.e. non-small cell lung cancer (NSCLC) [149], esophageal squamous cell carcinoma [150], gastric adenocarcinoma [151] and breast cancer [152].…”
Section: Hla-f In Tumorsmentioning
confidence: 99%
“…The HLA-F locus has been unraveled in the recent years as an immunomodulatory gene (Goodridge et al 2010). Similar to HLA-G, its expression in the tumor leads to tumor cell escape from the NK cell cytotoxicity and consequently to poor prognosis of the disease (Harada et al 2015;Xu et al 2015). HLA-F may play an important role on the maintenance of immunotolerance in feto-maternal interface, since it is expressed at the extravillous trophoblasts, during the first and second trimesters (Ishitani et al 2003;Shobu et al 2006), but it is absent at the third one (Hackmon et al 2017).…”
Section: Overview On Non-classical Class I (Hla)-fmentioning
confidence: 99%